Expensify (EXFY) Launches $25M Dutch Auction Tender Offer at $0.98–$1.20 Per Share

The Offer

Expensify, Inc. (Nasdaq: EXFY), the expense-management software company, filed an issuer tender offer (Schedule TO-I) on May 13, 2026 to buy back up to $25 million of its Class A common stock through a modified Dutch auction. Shareholders can elect to tender shares at any price between $0.98 and $1.20 per share, in $0.02 increments. The company will then pick the single lowest price that lets it buy the full $25M and pay that clearing price to every shareholder whose tender was at or below it.

The offer expires at midnight ET at the end of June 10, 2026. If fully subscribed, Expensify will retire between 20.8 million shares (at the $1.20 cap) and 25.5 million shares (at the $0.98 floor) — roughly 25.9% to 31.7% of the 80,375,990 Class A shares outstanding as of the most recent record date (April 22, 2025 proxy). The board has approved the buyback, but there is no formal recommendation that shareholders tender (standard for issuer tenders). Directors and executive officers as a group have indicated they will not tender, but that group only holds 4.95M Class A shares (6.0% of Class A), and CEO David Barrett's entire 3.24M Class A position is pledged as loan collateral and would be encumbered from participation regardless.

Share Structure: There Is No Class B

Expensify has a tri-class structure that is unusual enough to be worth pinning down before discussing who might tender. Class A common stock (1 vote per share) has 80,375,990 shares outstanding — this is the only class the tender offer covers. There are two high-vote classes: LT10 (10 votes per share, 4,209,827 shares) and LT50 (50 votes per share, 7,794,109 shares). Both are 100% held through the Expensify Voting Trust, whose trustees (Barrett, Garrett Knight, Jason Mills) have sole voting discretion. The Trust controls roughly 84% of total voting power but owns zero Class A — it is therefore not eligible for this tender at all.

The practical upshot: the tender is a pure Class A event. Voting control sits with the LT10/LT50 holders through the Voting Trust and does not change as a result of the buyback. What changes is the Class A economic share count, which shrinks by 26–32% if the deal fully clears.

Why This Is Interesting

The mechanics of this deal are clean: no financing condition, no minimum tender condition, $66.5M of cash on the balance sheet at the end of Q1 2026 against a $25M check size. The money is there. There is no regulator to wait on, no antitrust review, no merger vote. Once the offer closes on June 10, accepted shares settle promptly — cash in hand within days, not months.

The wrinkle is that Expensify is doing this at the bottom of its trading range. EXFY printed $0.75 in the past 12 months and traded as high as $2.61. The current price of $1.15 sits inside the offer's $0.98–$1.20 band, which means the market is effectively saying "we trust the company to clear near the top." If you tender at $1.20 and the clearing price comes in at $1.18, you get nothing and watch shares you wanted to sell trade back to wherever they were. If you tender at $0.98, you are guaranteed to be accepted but accept whatever the clearing price ends up being — which could be $0.98 itself in a heavily subscribed scenario.

For odd-lot holders, the calculus simplifies considerably. Anyone who beneficially owns fewer than 100 shares and tenders all of them is exempt from proration entirely. They get filled at the final clearing price regardless of how oversubscribed the offer is. Pair that with no minimum condition and a fully cash-funded buyer, and the small-position version of this trade is one of the cleanest setups on the calendar.

How the Dutch Auction Actually Works

A modified Dutch auction is just a price-discovery mechanism. You tell the company two things: how many shares you want to sell, and the minimum price you'll accept (anywhere from $0.98 to $1.20 in $0.02 steps). After the deadline, Expensify stacks all the tendered shares from lowest price to highest, walks up the stack until it has enough to spend $25M, and stops. That last price becomes the clearing price. Everyone who tendered at or below it gets paid the clearing price for their shares. Everyone who tendered above gets their shares back, untouched.

Two practical implications. First, tendering at $0.98 is the only way to absolutely guarantee acceptance — you're saying "I'll take whatever clears, even the minimum." Second, the clearing price is the same for everyone who participates, even someone who tendered at $0.98. So tendering low does not mean getting a worse price than someone who tendered higher; it just means you participate in the auction no matter where it settles.

The Odd-Lot Play

The single most actionable feature here is the odd-lot priority. Holders of fewer than 100 shares (an "odd lot") who tender all of them are pulled out of the proration pool and accepted before any other tendered shares. Two conditions: (1) you must hold fewer than 100 shares as a beneficial owner across all accounts at the depositary, and (2) you must tender every share you own.

The practical play: buy 99 shares of EXFY at the current $1.15 and tender all 99 at $0.98 to guarantee acceptance. Your downside if the auction clears at $0.98 is about $16.83 (the $0.17 per-share loss times 99 shares, before commissions). Your upside if the auction clears at $1.20 is about $4.95 (a $0.05 gain per share). That's a roughly 3-to-1 negative skew on price, so the trade only makes sense if you have a view that the auction clears above the current market.

A cleaner version: buy 99 shares only if EXFY trades below $1.00 between now and the deadline, and tender at $0.98. Then the math flips in your favor. Without that price improvement, the headline odd-lot mechanic is real but the spread is thin.

Proration Scenarios (For Larger Holders)

Holders of 100 or more shares are subject to proration if the offer is oversubscribed at the clearing price. The dollar cap of $25M is the binding constraint. The scenarios below assume Expensify clears at the midpoint of the range ($1.09), which translates the $25M budget into about 22.9 million shares of capacity against 80,375,990 Class A outstanding.

Directors and officers as a group hold only 6.0% of Class A and have indicated they will not tender. That removes at most ~4.95M shares from the tendering pool — and Barrett's 3.24M pledged shares could not participate even if he wanted to. The bigger swing factors are the two outside 5% holders. Steve McLaughlin owns 9,892,832 Class A shares (12.3%) and Octopus Head Inc. owns 6,456,400 (8.0%). If either tenders a substantial portion at the low end of the range, the auction can clear at or near $0.98; if both abstain or tender only at $1.20, the deal can settle near the cap. With ~16.3M Class A held by these two holders against $25M / ~22.9M shares of capacity at the midpoint, their decision swamps everything insiders do.

Key Terms

• Price range: $0.98 to $1.20 per share, $0.02 increments. Final clearing price determined after expiration.
• Maximum spend: $25,000,000.
• Expiration: midnight ET, June 10, 2026 (brokers typically impose an earlier internal deadline — confirm with yours).
• Source of funds: cash on hand. Expensify reported $66.5M in cash and equivalents as of March 31, 2026.
• Financing condition: none.
• Minimum tender condition: none. The company can complete the offer no matter how few shares are tendered.
• Odd-lot priority: yes, for holders of fewer than 100 shares who tender all of them.
• Proration: applies to holders of 100 or more shares if the dollar cap is exceeded at the clearing price.
• Withdrawal rights: shares can be withdrawn any time before expiration.
• Insider participation: directors and executive officers (6.0% of Class A in aggregate) have indicated they will not tender. CEO David Barrett's 3.24M Class A shares are pledged as loan collateral and would be encumbered from participation regardless.
• Voting Trust: holds 100% of LT10 (10 votes/share) and LT50 (50 votes/share) — roughly 84% of total voting power — but owns zero Class A and is not eligible for this tender.
• Other 5% Class A holders: Steve McLaughlin (12.3%) and Octopus Head Inc. (8.0%) — their tender decisions are the dominant variable in where the auction clears.
• Regulatory approvals: none required.

Timeline

Tax Treatment

Issuer tender offers are taxed under IRC Section 302. If your sale into the tender is treated as "substantially disproportionate" — generally, you reduce your percentage ownership by at least 20% and end up below 50% of voting power — it's taxed as a capital gain or loss, based on your cost basis. For nearly every retail holder, that test is easily met and capital gains treatment applies.

If you fail the disproportionate test (concentrated insider-style positions), the entire proceeds can be re-characterized as a dividend, taxable at ordinary income rates against current earnings and profits. That's vanishingly unlikely for anyone holding 99 shares, but it is the standard issuer-bid wrinkle worth knowing about. See SEC.gov on tender offer mechanics for general background.

Why Now? Reading the Signal

Expensify's Q1 2026 revenue declined 6% year over year to $34.0M, and the stock has spent most of the past year between $0.75 and $1.50. Buying back 26–32% of the Class A float in the $1.00 area looks opportunistic. With $66.5M of cash and a roughly $100M market cap, the math says the company would rather shrink the Class A count than sit on idle cash at depressed prices. Insiders not tendering is a qualitative alignment signal, but it should not be over-read: the directors-and-officers group only holds 6.0% of Class A in the first place, and Barrett's 3.24M shares are pledged as collateral and cannot be tendered. The Voting Trust's LT10/LT50 stack — which controls voting outcomes — is ineligible for this Class A tender entirely, so management's "skin in the game" here is mostly about voting control they already keep rather than economic alignment with Class A holders.

Skeptically: the company has been declining revenue for multiple quarters and is using a meaningful chunk of its cash buffer to do this. If the business deteriorates further, the buyback will look like a poorly timed return of capital that could have funded a turnaround. For tender-offer participants that risk doesn't matter — you're out in cash by mid-June. For anyone considering holding through the close, it's the central question.

Risks

• Price risk inside the auction: tender too high and you get nothing back; tender at $0.98 and you may collect $0.98 in a fully subscribed scenario. The current $1.15 market price is not a floor.
• Proration risk for non-odd-lot holders: in a fully subscribed deal, only about a quarter of tendered shares may be accepted. The rest come back to you at the post-deal market price, which can drift.
• Post-tender share-price risk: once the buyback completes, the technical bid disappears. Stocks often soften after issuer tender offers close, especially when the underlying business is weakening.
• Extension or amendment risk: Expensify reserves the right to extend the deadline, change the price range, or amend other terms (with some restrictions). An extension delays your cash for weeks.
• Business risk: revenue is declining. This is not a deep-value catalyst event — it is a capital-structure cleanup at a depressed price. Anyone tendering should expect to be out in cash, not holding the remaining shares as a long-term position.
• Commissions and broker fees can swamp the odd-lot return on 99 shares. Use a commission-free broker; otherwise the trade is not worth it.

The Bottom Line

Expensify's tender offer is mechanically clean: fully cash-funded, no minimum condition, no regulatory drag, an explicit odd-lot priority. But the Dutch auction structure means there's no fixed premium to capture — you are bidding into an auction that could clear anywhere from $0.98 to $1.20, and the current $1.15 market price already sits near the top of the range. The risk/reward on tendering 99 shares from current levels is mildly negative; the trade gets interesting only if EXFY trades back below $1.00 before the June 10 deadline, in which case the odd-lot guaranteed acceptance becomes a real edge.

For larger holders already owning EXFY, the better question is whether to use this as exit liquidity. With the company itself bidding for 26–32% of the Class A float, this may be the deepest bid the stock sees for a while — though whether McLaughlin or Octopus Head step into the auction will determine how much capacity is actually available to smaller holders after proration. Tendering at $0.98 ensures acceptance subject to proration; tendering higher is a bet on where the clearing price lands. Either way, treat the proceeds as exit liquidity, not a setup to hold the rump position. Read the SC TO-I on EDGAR and the related Offer to Purchase for full terms before submitting your tender.

This analysis is for informational purposes only and does not constitute investment advice. Read the complete filing and consult your own advisors before making any decisions.